Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Mallinckrodt PLC MCKPF

Healthcare Drug Manufacturers - Specialty & Generic
Mallinckrodt plc develops, manufactures, markets, and distributes branded and generic specialty pharmaceutical products and therapies. The Company operates in two reportable segments: Specialty Brands and Specialty Generics. The Specialty Brands includes specialty pharmaceutical brands. The Specialty Generics includes niche specialty generic drugs and active pharmaceutical ingredients. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:MCKPF)

Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance

PR Newswire March 26, 2024

Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients

PR Newswire March 11, 2024

Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands

PR Newswire March 4, 2024

Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector

PR Newswire March 1, 2024

Mallinckrodt Announces Board of Directors and Leadership Updates

PR Newswire February 2, 2024

Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress

PR Newswire January 22, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mallinckrodt plc - MNK

PR Newswire March 22, 2023

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK

PR Newswire March 21, 2023

Mallinckrodt Receives Approval to List on NYSE American

PR Newswire October 24, 2022
View More News ››

Opinion & Analysis (OTCPK:MCKPF)

Mallinckrodt Shares Up 60% as It Announces Sale of Unit

Streetwise Reports September 11, 2019

Three shots on goal in Q4/16 for DURECT Corp.

The Life Sciences Report September 8, 2016

ETFs For The Next Pharma Takeover Candidates

Benzinga.com  July 28, 2015

3 Cinderella ETFs For March Madness

Benzinga.com  March 17, 2015
View More Opinion ››

Bullboard Posts (OTCPK:MCKPF)

$MNK Securities Class Action Survives Motion to Dismiss

If you purchased $MNK shares between 8/7/17 and 11/7/17 and would like to learn more, please contact me at jgrabar@grabarlaw.com or 267...
JGrabar - April 13, 2020

Looks like this has bottomed out

OnlyCan go up from here I’ll see six or seven and 4 to 6 weeks
jessyjamz - September 13, 2019

huge news this is big UMB

The expansion plan includes two buildings and four phases of construction. The first phase is a building envelope of 130,000 sq ft. ...
wintersky - July 6, 2017

Nuvo Research V. Mallinckrodt Pennsaid 2% Dispute Trial Case

NRI vs MNK is setting up like David versus Goliath. My editorial take on some recent developments of this ongoing dispute: a) Nuvo has...
Schaffhausen - March 6, 2014

Mallinckrodt Senior VP Leaving the Company - Tom Berry, Senior VP, Product Supply

MNK Senior VP of Product Supply, Tom Berry, departing MNK as of Sept.30.  This announcement was filed by MNK in an 8-K form with the...
Schaffhausen - August 24, 2013

Mallinckrodt Untimely Disclosure of Contractual Breach vs Nuvo Research

On April 10, a formal notice of breach pursuant to the agreement with Nuvo Research was sent to Covidien (herein MNK).  According to...
Schaffhausen - August 22, 2013
View more Bullboard ››

Imagine Lithium Inc.

Imagine Lithium Inc.

Imagine Lithium is an exploration company advancing its Jackpot Lithium Project in Nipigon, Ontario. The project has a ...
View More »